Year: 2016
Type: conference-paper
Abstract: Cachexia is a major adverse effect of prostate cancer (PCa) and leads to functional impairment and poor quality of life. The pathophysiology of cachexia is complex and includes an imbalance of anabolic and catabolic factors. Oncologists often encourage nutritional and physical interventions to improve cancer outcomes. However, it is unclear how these interventions affect the pathophysiology of PCa-induced cachexia. PURPOSE: To test the hypothesis that exercise and Nexrutine® (a natural product derived from the bark of the Amur cork tree) can modulate cachexia in a transgenic adenocarcinoma of mouse prostate (TRAMP) model. METHODS: Ten-week old TRAMP mice were randomized into three groups, voluntary wheel running (VWR; n=7), Nexrutine® (Nex; 600 mg/kg; n=6) and control (Con; n=6), and studied over an eight-week time frame. Grip strength was measured at 0, 5 and 8 weeks. At weeks 5 and 8, animals were euthanized and gastrocnemius muscle was dissected, weighed and snap frozen until analysis. A 1-2 mm piece of muscle was homogenized in 1 mL of phosphate buffered saline, sonicated and centrifuged for 5 minutes at 5,000 rpm. Supernatant was collected to measure insulin-like growth factor (IGF)-1 and myostatin with commercially available ELISA kits. A multivariate analysis of variance was performed using Tukey’s post hoc test with significance set at p: The results of this pilot study suggest that exercise can increase intramuscular IGF-1 during the early stages of PCa development. However, the benefits of exercise in modulating IGF-1 may be neutralized with the marked increase in myostatin. Longitudinal studies need to be carried out to better understand IGF-1 and myostatin’s influence on the onset and progression of PCa-induced cachexia.
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2287853040